A study of human tumor cells implanted in mice from the MacPherson Lab at Fred Hutch describes a new way to screen for the ...

Learn about April 2025’s top biotech deals, featuring major collaborations in bispecific antibodies, protein therapies, and ...

Roche’s Genentech unit signed a trio of deals this week to add new drug discovery platforms to its repertoire. The three drug discovery deals are with Convelo Therapeutics in neurological ...

Patients who are immunocompromised still can receive a variety of vaccinations based on their specific needs, Cassandra ...

Dr. Stephen Hauser has spent over 40 years of his professional career studying and researching Multiple Sclerosis. The ...

Plans expect cell and gene therapies to pose a moderate or major financial challenge in the next two to three years, ...

Like most of its peers in the biopharma sector, Genentech has been working on AI-powered technologies for drug discovery and development, coming up with a proprietary set of algorithms and other ...

But Harding’s doctors offered only tests and prescriptions that led nowhere. One prescribed an inhaler and, when it didn’t ...

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of ...

Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology, announced today that the first patient has been dosed in the ...

Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article ...